Abstract: Sustained-release abiraterone prodrug formulations, methods, and kits for parenteral administration to a subject having a sex hormone-dependent benign or malignant disorder such as prostate cancer, an androgen receptor driven cancer, a syndrome due to androgen excess, and/or a syndrome due to glucocorticoid excess such as hypercortisolemia.

Abstract: A system and a computer-implemented method for providing responder information are disclosed herein. The method includes receiving, via a computing device, a sensor data generated by one or more safety devices corresponding to one or more responders. The computer-implemented method further includes analyzing, via the computing device, the sensor data to generate an analyzed sensor data. The computer-implemented method further includes establishing, via an application programming interface (API), a direct communication link between the computing device and at least one server or establishing, via a local application, a direct communication link between the computing device and at least one third party server. The computer-implemented method further includes transmitting, via the computing device, the analyzed sensor data to the at least one server or transmitting, via the computing device, the analyzed sensor data to the at least one third party server.

Abstract: Sustained-release abiraterone prodrug formulations, methods, and kits for parenteral administration to a subject having a sex hormone-dependent benign or malignant disorder such as prostate cancer, an androgen receptor driven cancer, a syndrome due to androgen excess, and/or a syndrome due to glucocorticoid excess such as hypercortisolemia.

Abstract: Systems and methods are provided for accessing medication claims data and converting medication claims to active medications. In one method, medication claims data corresponding with a number of medication claims is accessed. The medication claims may then be presented to a clinician, who may manually review and determine the claims that a patient may currently be taking. Accordingly, a medication claim may be selected and converted to an active medication. A clinician may wish to convert a medication claim to an active medication for record purposes, such as for interaction checking, for example, and/or may wish to convert a medication claim to an active medication to manage the medication for the patient.

Abstract: A syringe includes a barrel defining a liquid chamber, an aperture and two or more contents indicators; a plunger movable within said barrel whereby movement of the plunger in a first direction causes the liquid chamber to fill with a fluid and movement by the plunger in a second direction causes fluid to be expelled from the liquid chamber through the aperture; and a selecting mechanism disposed on the barrel that is actuated to select only one of the contents indicators.

Abstract: Systems and methods are provided for facilitating the conversion of medication claims to active medications by identifying medication claims that correspond with medications that a patient may be currently taking. In one method, medication claims data corresponding with a number of medication claims is accessed. A determination is made for each medication claim whether the medication claim corresponds with a medication that the patient is currently taking. The medication claims are presented with an indication provided for each medication claim determined to correspond with a current medication for the patient. A clinician may then review the medication claims and easily identify and select medication claims for conversion to active medications.

Abstract: Systems and methods are provided for accessing medication claims data and converting medication claims to active medications. In one method, medication claims data corresponding with a number of medication claims is accessed. The medication claims may then be presented to a clinician, who may manually review and determine the claims that a patient may currently be taking. Accordingly, a medication claim may be selected and converted to an active medication. A clinician may wish to convert a medication claim to an active medication for record purposes, such as for interaction checking, for example, and/or may wish to convert a medication claim to an active medication to manage the medication for the patient.

Abstract: A syringe includes a barrel defining a liquid chamber, an aperture and two or more contents indicators; a plunger movable within said barrel whereby movement of the plunger in a first direction causes the liquid chamber to fill with a fluid and movement by the plunger in a second direction causes fluid to be expelled from the liquid chamber through the aperture; and a selecting mechanism disposed on the barrel that is actuated to select only one of the contents indicators.

Abstract: The invention is a towing attachment which can be attached to the towbar of a towing vehicle in order to allow easier towing of trailers by moving into position under the trailer. The towing attachment can also be used to lift the towing vehicle off the ground with a tongue attachment for better traction in snow.